Generation of induced pluripotent stem cell line CSSi008-A (4698) from a patient affected by advanced stage of Dentato-Rubral-Pallidoluysian atrophy (DRPLA)-Reference-Cited by-同舟云学术

Generation of induced pluripotent stem cell line CSSi008-A (4698) from a patient affected by advanced stage of Dentato-Rubral-Pallidoluysian atrophy (DRPLA)

Published:2019-10 Issue: Volume:40 Page:101551
ISSN:1873-5061
Container-title:Stem Cell Research
language:en
Short-container-title:Stem Cell Research

Author:

Bidollari Eris,Rotundo Giovannina,Altieri Filomena,Amicucci Mariangela,Wiquel Daniele,Ferrari Daniela,Goldoni Marina,Bernardini Laura^ORCID,Consoli Federica,De Luca Alessandro,Fanelli Sergio,Lamorte Giuseppe,D'Agruma Leonardo,Vescovi Angelo Luigi,Squitieri Ferdinando,Rosati Jessica

Funder

Italian Ministry of Health: Ricerca Corrente

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,General Medicine

Reference6 articles.

1. Dentatorubral-pallidoluysian atrophy and Haw River syndrome;Burke;Lancet.,1994

2. Prevalence of dentatorubral-pallidoluysian atrophy in a large series of white patients with cerebellar ataxia;Le Ber;Arch. Neurol.,2003

3. European molecular genetic quality network (EMQN). EMQN/CMGS best practice guidelines for the molecular genetic testing of Huntington disease;Losekoot;Eur J Hum Genet. May,2013

4. Case control analysis of repeat expansion size in ataxia;Majounie;Neurosci. Lett.,2007

5. Familial myoclonus epilepsy and choreoathetosis: hereditary dentatorubral-pallidoluysian atrophy;Naito;Neurology.,1982

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atrophin‐1 Function and Dysfunction in Dentatorubral–Pallidoluysian Atrophy;Movement Disorders;2023-02-21

2. Exosomal MicroRNAs as Brain Memory Devices;The MicroRNA 2000 Transformer;2023

3. Pallidal degenerations and related disorders: an update;Journal of Neural Transmission;2021-08-07

4. Human stem cell models of polyglutamine diseases: Sources for disease models and cell therapy;Experimental Neurology;2021-03

5. DRPLA: understanding the natural history and developing biomarkers to accelerate therapeutic trials in a globally rare repeat expansion disorder;Journal of Neurology;2020-10-26